Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.36 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.35 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.34 |
| ▸ | CTSK | P43235 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 4/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | FDPS | P14324 | 1/20 | 0.31 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL597280 | 0.95 | LMNA (0.41) | LMNADNM1OPRM1ACE2CTSK | |
| SCHEMBL27345411 | 0.92 | OPRM1 (0.44) | LMNADNM1OPRM1ACE2TSHR | |
| SCHEMBL1645053 | 0.90 | ACE2 (0.45) | LMNADNM1OPRM1ACE2TSHR | |
| SCHEMBL27223874 | 0.90 | ACE2 (0.45) | LMNADNM1OPRM1ACE2TSHR | |
| SCHEMBL27470379 | 0.90 | ACE2 (0.45) | LMNADNM1OPRM1ACE2TSHR | |
| SCHEMBL2504628 | 0.89 | DNM1 (0.43) | LMNADNM1OPRM1ACE2ALDH1A1 | |
| SCHEMBL9530349 | 0.88 | LMNA (0.50) | LMNADNM1OPRM1ACE2FDPS | |
| SCHEMBL1873151 | 0.86 | OPRM1 (0.48) | LMNADNM1OPRM1ACE2TSHR | |
| SCHEMBL9175617 | 0.86 | TSHR (0.43) | LMNADNM1OPRM1ACE2ALDH1A1 | |
| SCHEMBL671349 | 0.84 | ACE2 (0.48) | LMNADNM1OPRM1ACE2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118098592-B | Cognitive disorder prediction system based on exhaled breath | 四川大学华西医院 | 2024-08-13 | — | — | CN | claimed |
| CN-117831756-B | Auxiliary analysis method, device, equipment and storage medium for cognitive impairment | 精智未来(广州)智能科技有限公司 | 2024-06-28 | — | — | CN | claimed |
| CN-118098592-A | Cognitive disorder prediction system based on exhaled breath | 四川大学华西医院 | 2024-05-28 | — | — | CN | claimed |
| CN-117831756-A | Auxiliary analysis method, device, equipment and storage medium for cognitive impairment | 精智未来(广州)智能科技有限公司 | 2024-04-05 | — | — | CN | claimed |
| CN-101923077-B | Method for detecting chemical components of ether extract of bitter gourd leaves | UNIV TIANJIN NORMAL | 2013-01-23 | — | — | CN | claimed |
| CN-101923077-A | Method for detecting chemical components of ether extract of bitter gourd leaves | UNIV TIANJIN NORMAL | 2010-12-22 | — | — | CN | claimed |
| WO-2010031788-A1 | METHOD FOR THE DIAGNOSIS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE BY DETECTING VOLATILE ORGANIC COMPOUNDS IN EXHALED AIR | UNIVERSITEIT MAASTRICHT (NL) | 2010-03-25 | — | — | WO | claimed |
| EP-2166355-A1 | Method for the diagnosis of chronic obstructive pulmonary disease by detecting volatile organic compounds in exhaled air | Universiteit Maastricht (NL) | 2010-03-24 | — | — | EP | claimed |
| EP-3515186-B1 | ECDYSOZOANS TRAP | INNOC SRL (BE) | 2025-11-26 | — | — | EP | disclosed |
| US-20250197341-A1 | METHOD FOR INHIBITING CRYSTALLISATION | BIOSYNTHIS (FR) | 2025-06-19 | — | — | US | disclosed |
| CN-118098592-B | Cognitive disorder prediction system based on exhaled breath | 四川大学华西医院 | 2024-08-13 | — | — | CN | disclosed |
| CN-118098592-B | Cognitive disorder prediction system based on exhaled breath | 四川大学华西医院 | 2024-08-13 | — | — | CN | disclosed |
| CN-117831756-B | Auxiliary analysis method, device, equipment and storage medium for cognitive impairment | 精智未来(广州)智能科技有限公司 | 2024-06-28 | — | — | CN | disclosed |
| EP-4387582-A1 | METHOD FOR INHIBITING CRYSTALLISATION | Biosynthis (FR) | 2024-06-26 | — | — | EP | disclosed |
| US-20180077917-A1 | ECDYSOZOANS TRAP | DOMOBIOS (BE) | 2018-03-22 | — | — | US | disclosed |
| US-20140276201-A1 | SYSTEM AND METHOD FOR DETECTING TISSUE STATE AND INFECTION DURING ELECTROSURGICAL TREATMENT OF WOUND TISSUE | ARTHROCARE CORPORATION (US) | 2014-09-18 | — | — | US | disclosed |
| CN-101923077-B | Method for detecting chemical components of ether extract of bitter gourd leaves | UNIV TIANJIN NORMAL | 2013-01-23 | — | — | CN | disclosed |
| CN-101923077-A | Method for detecting chemical components of ether extract of bitter gourd leaves | UNIV TIANJIN NORMAL | 2010-12-22 | — | — | CN | disclosed |
| WO-2010031788-A1 | METHOD FOR THE DIAGNOSIS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE BY DETECTING VOLATILE ORGANIC COMPOUNDS IN EXHALED AIR | UNIVERSITEIT MAASTRICHT (NL) | 2010-03-25 | — | — | WO | disclosed |
| EP-2166355-A1 | Method for the diagnosis of chronic obstructive pulmonary disease by detecting volatile organic compounds in exhaled air | Universiteit Maastricht (NL) | 2010-03-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250197341-A1 | METHOD FOR INHIBITING CRYSTALLISATION | FASN, SCD5, NFKB2 | LMNA 149/4885DNM1 1631/4885OPRM1 4200/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.